読み込み中
Senseonics Holdings, Inc. operates as a medical technology enterprise, specializing in the development and commercialization of continuous glucose monitoring (CGM) systems. These innovative solutions cater to individuals with diabetes across the United States, Europe, the Middle East, and Africa. The company's core product offerings, Eversense and Eversense XL, are advanced implantable CGM devices. They function by continuously tracking glucose levels through an under-the-skin sensor, a detachable and rechargeable smart transmitter, and an intuitive mobile application. This setup enables real-time diabetes monitoring and management for durations of up to half a year. Senseonics delivers its products and services to healthcare providers and patients alike via an extensive network of distributors and strategic fulfillment partners. Additionally, the firm maintains a collaborative agreement with the University Hospitals Accountable Care Organization. Founded in 1996, Senseonics Holdings, Inc. is headquartered in Germantown, Maryland.
前日終値
$8.98
−$0.04 · -0.44%
日中の時刻はETです。市場データは遅延する場合があります。
Senseonics Holdings, Inc. operates as a medical technology enterprise, specializing in the development and commercialization of continuous glucose monitoring (CGM) systems. These innovative solutions cater to individuals with diabetes across the United States, Europe, the Middle East, and Africa. The company's core product offerings, Eversense and Eversense XL, are advanced implantable CGM devices. They function by continuously tracking glucose levels through an under-the-skin sensor, a detachable and rechargeable smart transmitter, and an intuitive mobile application. This setup enables real-time diabetes monitoring and management for durations of up to half a year. Senseonics delivers its products and services to healthcare providers and patients alike via an extensive network of distributors and strategic fulfillment partners. Additionally, the firm maintains a collaborative agreement with the University Hospitals Accountable Care Organization. Founded in 1996, Senseonics Holdings, Inc. is headquartered in Germantown, Maryland.
日中レンジ
現在 $8.98
52週レンジ
現在 $8.98
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
売り
バリュエーション
37
割高
センチメント
63
強気
リスク
68
高リスク
モメンタム
22
弱含み
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
Senseonics Holdings, Inc. operates as a medical technology enterprise, specializing in the development and commercialization of continuous glucose monitoring (CGM) systems. These innovative solutions cater to individuals with diabetes across the United States, Europe, the Middle East, and Africa. The company's core product offerings, Eversense and Eversense XL, are advanced implantable CGM devices. They function by continuously tracking glucose levels through an under-the-skin sensor, a detachable and rechargeable smart transmitter, and an intuitive mobile application. This setup enables real-time diabetes monitoring and management for durations of up to half a year. Senseonics delivers its products and services to healthcare providers and patients alike via an extensive network of distributors and strategic fulfillment partners. Additionally, the firm maintains a collaborative agreement with the University Hospitals Accountable Care Organization. Founded in 1996, Senseonics Holdings, Inc. is headquartered in Germantown, Maryland.
日中レンジ
現在 $8.98
52週レンジ
現在 $8.98
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標（USD） | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 3525.7万 USD | 2247.2万 USD | 2239万 USD | 1638.9万 USD | 1367.5万 USD |
| 売上原価 | 1949.4万 USD | 2193.9万 USD | 1929.9万 USD | 1366.3万 USD | 1448.6万 USD |
| 粗利益 | 1576.3万 USD | 53.3万 USD | 309.1万 USD | 272.6万 USD | −81.1万 USD |
| 研究開発 | 3159.2万 USD | 4114.4万 USD | 4875.2万 USD | 3971.9万 USD | 2721.7万 USD |
| 販売・一般管理 | 5250.8万 USD | 3423.1万 USD | 2994.2万 USD | 3163.4万 USD | 2915.4万 USD |
| 営業費用 | 8410万 USD | 7537.5万 USD | 7869.4万 USD | 7135.3万 USD | 5637.1万 USD |
| 受取利息 | 419.8万 USD | 450.2万 USD | 536.2万 USD | 182.4万 USD | 24.3万 USD |
| 支払利息 | 495.1万 USD | 843.7万 USD | 1111万 USD | 1870.3万 USD | 1672万 USD |
| 減価償却費と償却費 | 151.2万 USD | 147.5万 USD | 127.7万 USD | 98.5万 USD | 123.9万 USD |
| 営業利益 | −6833.7万 USD | −7484.2万 USD | −7560.3万 USD | −6862.7万 USD | −5718.2万 USD |
| 純利益 | −6911.3万 USD | −7861.6万 USD | −6039.2万 USD | 1.42億 USD | −3.02億 USD |
会社概要が更新されました 2026年10月11日.
直近の発表実績
直近の発表実績
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
平均目標
$13.00
上昇余地（44.77%）| 種別 | 発効日 | 詳細 | 基準日 | 支払日 |
|---|---|---|---|---|
株式分割 | 2025年10月20日 | 1:20 | — | — |
発効済み 2025年10月20日
1:20
この株式へのエクスポージャーを報告している上場投資信託です。
Vanguard Morningstar Total Stock Market ETFVTI1084.7万0.00%2.3兆 USD0.03%$381.94+0.63%
iShares Russell 2000 ETFIWM893.34万0.01%787.4億 USD0.19%$278.94+0.49%
Vanguard Extended Market ETFVXF519.14万0.01%954億 USD0.05%$235+0.80%
iShares Russell 2000 Growth ETFIWO313.18万0.02%139.17億 USD0.24%$356.78+0.94%
Schwab U.S. Small-Cap ETFSCHA234.99万0.01%218.24億 USD0.03%$32.79+0.40%
Vanguard Russell 2000 ETFVTWO209.11万0.01%180億 USD0.06%$112.66+0.50%
Invesco Dorsey Wright SmallCap Momentum ETFDWAS144.14万0.36%3.99億 USD0.60%$107.24+1.40%
iShares Micro-Cap ETFIWC106.33万0.08%13.17億 USD0.60%$183+0.11%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFiShares Russell 2000 Growth ETFIWOSchwab U.S. Small-Cap ETFSCHAVanguard Russell 2000 ETFVTWOInvesco Dorsey Wright SmallCap Momentum ETFDWASiShares Micro-Cap ETFIWCAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
